Related by context. All words. (Click for frequent words.) 42 Generalists 41 Hypoglycaemia 41 silent myocardial ischemia 41 HINTS 41 ß blockers 40 celiac disease gluten intolerance 40 DOSAGE AND ADMINISTRATION 39 renal allograft 39 extensive metabolizers 39 WHAT ADVICE 39 ACEIs 39 Dr Fundanga 39 concomitant medications 39 Generalized Anxiety Disorder 39 AND RECOMMENDATIONS 39 OSAHS 39 Product Characteristics 38 Coeliac Disease 38 hepatic insufficiency 38 hypomagnesemia 38 HEART FAILURE 38 FOR AN OPEN 38 migraine prophylaxis 38 Social Phobia 38 dermatitis herpetiformis 38 enteral feedings 38 hypochondriasis 38 schizophreniform 38 Modifiable 38 RESPONSIBILITIES 38 idiopathic myelofibrosis 38 Promotional Audit 38 nonfasting 38 Hepatotoxicity 38 Lamotrigine 38 CPT coding 38 poor metabolizers 38 INTERIM REPORT 38 amisulpride 37 Matthew Emmens Chief Executive 37 thiazide 37 FULL PRESCRIBING INFORMATION 37 Karen Poutasi 37 Prescribers 37 ACA ACCA CIMA 37 Diagnostic Criteria 37 primary aldosteronism 37 Hypoglycemia 37 DIFFERING 37 THIS POST 37 Cognitive Behavior Therapy 37 Quantifiable 37 lyme 37 Clinical Practice Guideline 37 Hypokalemia 37 PHQ 37 Meta Analyses 37 Polycythemia Vera 37 CIOs COOs 37 contraindications 37 gluten sensitive enteropathy 37 pharmacologic treatments 37 affective psychoses 37 quantitative reasoning 37 neuroleptic 37 Interpersonal skills 37 Kathy Ordoñez Chief Executive 37 reflux symptoms 37 VNS Therapy TM 37 Ketogenic diet 37 ASST 37 Reassignments 37 textisms 37 PROJECT MANAGEMENT 37 NBSSI 37 unmeasured confounders 37 akinetic mutism 37 BEXXAR Therapeutic Regimen 37 REFLECT 36 HATE CPAP 36 mild renal insufficiency 36 paroxysmal nocturnal haemoglobinuria 36 familial hypercholesterolaemia FH 36 ophthalmologists Eye MDs 36 EMPLOYMENT AND 36 Prescriber 36 rheumatological 36 neutropaenia 36 Autistic Spectrum 36 usp 36 olanzapine LAI 36 MDs DOs 36 VCAM 1 36 DO NOT WORK 36 prescribing statins 36 RNLD 36 www.blackbaud.com 36 CCAB qualified 36 premorbid 36 haematological 36 PRECAUTIONS 36 Glucose Screening 36 Generalist 36 T2DM 36 Latex Allergy 36 Pharmacoeconomic 36 anticholinergic agents 36 Clinical Guideline 36 TECHNOLOGIES LIMITED 36 affective psychosis 36 CeFA 36 APPLICATION FORM 36 Oral Appliances 36 Adverse Reaction 36 celiac sprue 36 intensive statin therapy 36 SEMINAR FOR 36 neurocognition 36 Mojtabai 36 Dr. Virginia Kaklamani 36 hematological parameters 36 RDs 36 surgically resectable 36 Suomen Terveystalo Oyj 36 postdischarge 36 symptom checklist 36 dysarthria 36 Atomoxetine 36 INSTITUTIONAL 36 aldosterone antagonists 36 mu opioid agonist analgesics 36 comorbid psychiatric 36 CYP#C# [001] 36 THE PAPERS 36 MMDAs 36 Professor Coiera 36 BLOOD SUGAR 36 helpfull 36 APDN routinely 36 Preoperatively 36 -Dariusz Snarski 36 SAP ABAP 36 See CLINICAL PHARMACOLOGY 36 HoDs 36 INFORMAL 36 symptomatology 36 hypovitaminosis D 36 histologic findings 36 SGPT 36 nonrandomized studies 36 Connexions Personal 36 Hypercholesterolemia 36 li ul 36 serotonin reuptake inhibitor 36 BACK PAIN 36 Hyperactivity 36 ceoforum.com.au How 36 Oppositional Defiant Disorder 36 Schizophrenia Treatment 36 CORE OM 36 somatoform disorders 36 EEG abnormalities 36 YOUR QUESTIONS 36 dyslipidaemia 36 Combo Therapy 36 osteopathic manipulative treatment 36 perseverative 35 pharmacologic therapies 35 Bill Forbes Pharm.D 35 Aspergers 35 SUSTIVA 35 attendings 35 www.jpmorgan.com ts 35 Visualization Tools 35 Person Specification 35 fructose intolerant 35 Reminyl galantamine 35 Matthew Opoku Prempeh 35 psychodynamic psychotherapy 35 ACCOMPLISH 35 induce orthostatic hypotension 35 EXPLANATORY STATEMENT 35 BPS IC 35 RNs LPNs 35 AST ALT 35 Diabetology 35 INVEGA ® 35 highly numerate 35 convergence insufficiency 35 BOXED WARNING 35 de novo AML 35 4.To 35 Analytical Method 35 noti 35 nicardipine 35 Treatment Outcomes 35 COMMUNICATING 35 RECOMMENDATIONS 35 www.dh.gov.uk 35 Communicating Effectively 35 topical NSAIDs 35 FPC CFP 35 -Kamal Saxena 35 CAVEATS 35 β blockers 35 FURTHER INFORMATION 35 nonadherent 35 EARNINGS AND 35 Secondment 35 positiv 35 smoldering multiple myeloma 35 Clinical Neuropsychology 35 HEARING LOSS 35 psychoactive medication 35 MY OPINION 35 Hematologic 35 Non Responders 35 fructose intolerance 35 Logo http:/www.newscom.com/cgi-bin/prnh/#/Magoos 35 MANNER OF 35 PRECAUTIONS Drug Interactions 35 impaired renal 35 Jay Lichter 35 arteriovenous fistulas 35 ® pioglitazone HCl 35 revises FY# 35 bacterial prostatitis 35 Massague 35 RISK MANAGEMENT 35 semistructured interview 35 RN LVN CNA 35 comorbid depression 35 mastocytosis 35 post herpetic 35 pharmacodynamic parameters 35 suboptimally 35 CORPORATE GOVERNANCE STATEMENT 35 neuropsychiatric symptoms 35 #.#g t #.#g t 35 endoscopic ultrasonography 35 jobseeking 35 Restless Legs Syndrome RLS 35 Mantoux test 35 'S ADDRESS 35 www.timewarnercable.com investors 35 DEAR CONCERNED 35 MAXALT 35 carotid intima media 35 www.westerncoal.com 35 ALI ARDS 35 moderate renal impairment 35 Mental Disorders DSM IV 35 SEIs 35 HSPI 35 pyridoxine 35 expressive aphasia 35 ADOPTION OF THE 35 Stapling Proposal 35 unfavorable cytogenetics 35 aortic regurgitation 35 Wiskott Aldrich syndrome 35 http:/www#.best-in-class.com/br#.htm 35 Lantus ® 35 GDPI 35 FINANCIAL ASSISTANCE 35 mportant 35 Carbamazepine 35 PDSs 35 prospective multicentre 35 ON HUMAN RIGHTS 35 Symbyax 35 Disorder ADHD 35 Treating Heart Failure 35 IAS IPS IFS 35 JAAPA 35 ACC AHA 35 SPANISH SPEAKING 35 Iris Loew Friedrich 35 Mental Health www.nimh.nih.gov 35 EXAMINE 35 hypothyroid 35 Erythropoietic 35 Depressants 35 Infectious Disease Clinical 35 COMMONLY 35 HAZAN 35 orthostatic 35 psychoeducation 35 formoterol LABA 35 REGULARLY 35 Exp w 35 OUTCOMES 35 www.gasb.org 35 www.nimh.nih.gov 34 OSTEOPOROSIS 34 receiving VELCADE 34 MEDICATION 34 www.MentorCapital.com 34 tonsillar hypertrophy 34 nonbeneficial 34 bowel polyps 34 CYP #D# 34 treatment emergent AEs 34 anticonvulsant medications 34 ADEAR 34 sleep apneas 34 CRISIL Ratings 34 Norpramin 34 Magaisa 34 Late Breaker 34 Irritable bowel syndrome 34 Orthomolecular Medicine 34 Fixed Dose Combinations 34 Studies #CL# #CL# #CL# 34 PAOs 34 diagnosing ADHD 34 POSITIVE PARENTING 34 Wechsler Adult 34 Thiamin 34 nonpharmacologic interventions 34 TWGs 34 REHN 34 elevated creatinine 34 recurrent headaches 34 benazepril 34 compulsive hoarding syndrome 34 PDGFR alpha 34 RH VALUES 34 noncognitive 34 thiazides 34 SLAS 34 qualifi cations 34 EBUS FNA 34 www.worldbank.org 34 intraclass correlation coefficients 34 MIGRAINE 34 D Sequenced Treatment 34 lymphoproliferative disorders 34 psa 34 Barbara Sahakian 34 prognostic markers 34 antidepressant monotherapy 34 www.interscience.wiley.com journal 34 CONTRAINDICATIONS 34 www.thesspa.com 34 Dr. Kari Stefansson 34 Orthomolecular 34 IS RACIST 34 agomelatine 34 RGNs 34 Reissue CD 34 Final Appraisal Determination 34 Thiamine 34 Generalised 34 plasma adiponectin 34 BALF 34 anticholinergics 34 Postoperative Ileus 34 psychopharmacological 34 prazosin 34 hypersomnia 34 MANAGING DIRECTOR 34 Competency Evaluation 34 weakly correlated 34 GLIADEL R Wafer 34 ASSAYS 34 Personalfn 34 Parameter File Inclusion 34 beta blockers calcium 34 Scintillometer Readings 34 COPING 34 ULTRAM ER 34 NIHSS score 34 UNETHICAL 34 Allopathic 34 Picis Perioperative Dashboard 34 masterservant 34 semistructured 34 website www.delhaizegroup.com 34 stb 34 stone formers 34 Anticoagulant 34 Carl A. Pelzel 34 Facilitator Guide 34 TMPRSS2 ERG 34 DESIRED 34 euthymic patients 34 antioxidant supplementation 34 Full Prescribing Information 34 MAINTENANCE TECH 34 Listen attentively 34 Alzheimer Disease AD 34 Hedgehog inhibitor 34 bladder dysfunction 34 POSITION AVAILABLE 34 baseline HbA1c 34 Nepru 34 glulisine 34 functional gastrointestinal disorders 34 prognostically 34 Symptom Checker 34 REGISTRAR 34 Complaint Handling 34 nasal obstruction 34 Garcia Manero 34 TMJ disorders 34 iPTH 34 mild hepatic impairment 34 embryonic lethality 34 nondrug approaches 34 IGRAs 34 Designated Clinics 34 Oral corticosteroids 34 SOCIAL CARE 34 SeniorCare Nutrition 34 Compoundingmdashthe actual mixing 34 Behavioral Neurology 34 differential diagnoses 34 Proha Plc 34 Informal inquiries 34 BLUE PROXY CARD 34 Blood Glucose Testing 34 MOs 34 Venmyn 34 grammar syntax 34 impaired hepatic 34 Antti Tanskanen 34 EYES ONLY 34 NUCYNTA R 34 http:/www.healthgrades.com 34 monolingual 34 semistructured interviews 34 Shariah Supervisory Board 34 epileptic syndromes 34 AAO HNS 34 beta blocker therapy 34 Venous thromboembolism 34 Concluding Remarks 34 ingest gluten 34 COL#A# 34 spirometric 34 SCHEMA 34 Lipo Flavonoid 34 dyspnoea 34 DSM IV Axis 34 DISORDERS 34 cytogenetic abnormalities 34 INDUSTRY TRENDS AND 34 Raman Uberoi 34 number NCT# ClinicalTrials.gov 34 YIELD ON 34 comprehension vocabulary 34 nih.gov 34 prescribe anti depressants 34 methodological limitations 34 pharmacologic stress testing 34 Shingles vaccine 34 Uniform CPA Exam 34 Lipoproteins 34 ImmuKnow assay 34 Posttraumatic Stress 34 tricyclic antidepressants TCAs 34 Subgroup analyzes 34 NorthPoint Domain 34 Fingolimod 34 antibiotic regimens 34 Clinical Molecular Genetics 34 Tardive Dyskinesia 34 ski lls 34 IAS 34 LTRA 34 Antonio Borges 34 selective agonists 34 Blepharospasm 34 Ruschitzka 34 Medication Adherence 34 cryptogenic 34 LIPSKY 34 Heikki Westerlund 34 Graduate Trainee 34 acoustic startle 34 Relapsing Remitting Multiple Sclerosis 34 zolpidem Ambien 34 Synuclein 34 hyperreflexia 34 Pelvic Organ Prolapse 34 schizoaffective 34 asperger 34 Dose adjustments 34 colorectal liver metastases 34 Lymphocytic 34 creatinine ratio 34 akathisia 34 HSCR 34 DEER CREEK NURSING 34 Pharmacologic 34 prescribed antipsychotic medication 34 Qualitative 34 Endocrine Disorders 34 Versus RTLS 34 Myelosuppression 34 antiretroviral naive 34 antiviral therapy 34 Suitably qualified 34 renal impairment 34 catheterisation 34 Strong interpersonal skills 34 MYCAMINE 34 Regression Analysis 34 guideline concordant 34 ADPKD 34 Clinical Outcome 34 CALAMOS 34 Highly Skilled Migrants 34 consu 34 BenzaClin R 34 muscarinic receptor 34 Product Characteristics SmPC 34 Practice Parameter 34 TRAVERSE 34 SHUAA GCC Investor 34 HbA 1c levels 34 completely resected 34 Antidepressant medications 34 NCCN Guidelines ™ 34 generalisable 34 HIV seropositive 34 Elaboration 34 bronchoalveolar lavage 34 comorbid 34 INVEGA 34 solifenacin 34 Hematological 34 Fecal Incontinence 34 REMUNERATION 34 Tg mice 34 TT genotype 34 Peer Advising 34 Pediatric Sleep 34 IFRSs 34 buspirone 34 Histopathological 34 CEOs MDs 34 Overactive Bladder 34 Bentwich 34 NEED HELP 34 SCPs 34 CYP#D# 34 STRATEGY FOR AN OPEN 34 APOE genotype 34 CLINICAL PHARMACOLOGY 34 ELND-#/AZD-# 34 Ms. Tavakoli 34 PHILIP RUDDOCK 34 phonophobia 34 afebrile 34 Treatment Regimens 34 nondepressed 34 adhd 34 paroxetine sertraline 33 psychometric tests 33 glycated hemoglobin HbA1c 33 malabsorption 33 SHORT TERM 33 Fiorinal 33 Decressin 33 CUSTOMER SERVICE REP 33 parkinsonian 33 LE ROUX 33 Interpersonal psychotherapy 33 Isaac Owusu Mensah 33 Cash Flow Statements 33 elevated bilirubin 33 Glimepiride 33 sinus node dysfunction 33 bothersome symptom 33 diffe 33 PKC inhibitors 33 ValueSelling 33 BCR/ABL1 33 Dr. Steven Woloshin 33 Neuropsychological 33 NOT KNOWING 33 VOTE AGAINST THE 33 Bi lingual 33 polycystic ovary syndrome 33 aspartate aminotransferase AST 33 pernicious anemia 33 atherosclerotic CVD 33 OKMETIC 'S 33 Socio demographic 33 sociologists anthropologists 33 Verbal Ability 33 PSIs 33 meta regression 33 CAEs 33 postgraduate trainees 33 WCST 33 Neurocognitive 33 Suboptimal 33 VERY MUCH 33 REFERENCES 33 Privileged User 33 impaired cognition 33 Christos Mantzoros 33 affective disorder 33 ALT elevations 33 Policies Procedures 33 placebo PBO 33 SGAs 33 Cytogenetic 33 Iris Shai 33 MyHealthNewsDaily 33 serologic tests 33 multi factorial 33 Nonalcoholic Fatty Liver Disease 33 ASPECTS 33 Dickersin 33 Inaudible. 33 FINANCIAL STATEMENTS 33 quando quando quando 33 lamivudine refractory patients 33 Heart Profilers 33 interstitial pneumonia 33 AUDIT COMMITTEE 33 DSPD 33 cardioembolic 33 Psychometric 33 Normal Pressure Hydrocephalus 33 TRIAL COUNSEL 33 ADCIRCA 33 HyQ 33 Brief Psychiatric 33 T1DM 33 PRESIDING 33 Citicoline 33 CREDIBLE 33 Roch Doliveux Chief Executive 33 FOR EXCELLENT QUALITY 33 ALL SHAREHOLDERS 33 Data Sufficiency 33 Known hypersensitivity 33 geriatric syndromes 33 Endocrinologists 33 Differential Diagnosis 33 Content Outline 33 Nonalcoholic Steatohepatitis 33 Comorbidities 33 concerne 33 elevated ALT 33 tirofiban 33 THE YEAR ENDED 33 Jouriles 33 Vasotrac 33 Generalized Anxiety Disorder GAD 33 Pat Mackin 33 Solid Tumor 33 Emil Kakkis MD Ph.D. 33 RESOURCE CENTRE 33 Generally Accepted Auditing Standards 33 CHANTIX 33 MANAGEMENT DISCUSSION AND ANALYSIS 33 APIDRA R 33 Rheumatologists 33 David E. Kandzari 33 moderate hepatic impairment 33 RELATION 33 APPROVE OF 33 Recent Accounting Pronouncements 33 ADVEXIN therapy 33 umol L 33 diovan 33 Multi Lingual 33 Gram stain 33 ALTE 33 Consultant Psychiatrist 33 CHOLESTEROL 33 Sumatriptan OS 33 www.cfainstitute.org 33 www.pmi.org 33 Monthly Fact Sheet 33 Chronic Myeloid Leukaemia 33 MRCP 33 Pneumonia vaccine 33 gonococcal 33 Aggrastat ® tirofiban hydrochloride 33 http:/www.standardandpoors.com 33 ON THE FOLLOWING 33 PREVENTION AND 33 GRECH 33 BEN BERNANKE 33 DIRECTORS REPORT CONTINUED 33 cbse 33 Technical Documentation 33 Abstract P# [002] 33 labetalol 33 Career Progression 33 Employee Satisfaction Survey 33 MOTIVATE 33 explanatory variables 33 schizophrenia schizoaffective disorder 33 MISRA C + 33 Questionnaires 33 Autistic Spectrum Disorders 33 SOLANA 33 psychiatric comorbidities 33 www.conferenceboard.ca 33 delusions hallucinations 33 euthymic 33 MDs PhDs 33 Bayesian methods 33 Dr Andreas Hohlbaum 33 PEDIATRIC 33 Cystic Fibrosis Questionnaire Revised 33 lactulose 33 calcium antagonists 33 Boaz Raviv Chief Executive 33 CYP#D# inhibitors 33 RELATED COMPANIES 33 perioperatively 33 Iron Deficiency Anemia 33 RESULTS CONFERENCE CALL INTERNET 33 VIIBRYD 33 BANKING AND 33 WONDER WHY 33 FUNCTIONING 33 CHILDREN WITH 33 EoE 33 temper dysregulation disorder 33 colorectal carcinogenesis 33 p = .# [002] 33 OADs 33 UGT#A# 33 insulin glulisine 33 CIVIL SOCIETY 33 PULMONARY 33 overactive bladder symptoms 33 vestibular disorders 33 Angina 33 Schizophrenics 33 TREATMENT OPTIONS 33 nondrug treatments 33 cognitive behavioral therapies 33 topical corticosteroids 33 Zevalin therapeutic regimen 33 fructosamine 33 TEC Confidence Index 33 anticholinergic drugs 33 recurrent tonsillitis 33 calcium antagonist 33 atopic 33 oral antidiabetes drugs 33 Giwercman 33 glycemia 33 headache abdominal pain 33 Atypical Antipsychotic 33 Intravenous Formulation 33 Platelet counts 33 subscore 33 insulin secretagogues 33 pathophysiological mechanisms 33 Diabetic Diet 33 VOLCKER 33 Von Willebrand Disease 33 CDISC standards 33 Excellent interpersonal skills 33 www.health.harvard.edu adviser 33 JOIN OUR 33 lichen planus 33 Shaji Kumar 33 PERLOS CORPORATION 33 Commandants 33 Harith Al Nabhani 33 overt nephropathy 33 Aurora Kinase 33 Adult ADHD 33 Likert scale 33 OF TABLES 33 SELZENTRY 33 Deputy Permanent Secretaries 33 Sociodemographic 33 INVEGA R 33 Angiograms 33 ACNP 33 GOOD GOVERNANCE 33 - SHAREHOLDERS EQUITY [001] 33 syncopal episode 33 tipranavir ritonavir 33 HYPERTENSION 33 KAS 33 schizophreniform disorder 33 PLEASE DOUBLE CLICK 33 Hyperkalemia 33 BEXXAR therapeutic regimen 33 prescribe statins 33 somatic complaints 33 USPSTF recommends 33 microarray gene expression 33 ACA CIMA 33 Krashen 33 High Functioning Autism 33 - MARKET SNAPSHOT [003] 33 adrenergic receptor agonists 33 FBPase 33 Helpfulness 33 prognostic indicators 33 Severe Asthma 33 hematopoietic malignancies 33 Kaldjian 33 Cognitive Impairment 33 Irritability 33 www.treas.gov 33 Adhesive strips 33 D. SACK 33 -Kahaani Ghar Ghar Ki 33 CONSUMER INFLATION 33 www.intuit.com 33 Speech Therapists 33 Chronic Inflammatory 33 FOR PUBLICATION 33 JOHN NEGROPONTE 33 idiopathic Parkinson disease 33 ECB Papademos 33 Chartered Marketer 33 pulmonary arterial 33 TAXUS ARRIVE 33 PARAGRAPH 33 Pass Fail 33 Alstrynomics 33 nonalcoholic steatohepatitis NASH 33 Visual Analogue Scale VAS 33 AND WEBCAST 33 WHAT IS RIGHT 33 Healthcare Professionals 33 DOING THIS 33 coumadin 33 Position Description 33 OR ADDITIONAL PHOTOS 33 ACCOUNTABLE 33 corneal thickness 33 HES CEL 33 HbA 1C 33 www.aaaai.org 33 ADHD ADD 33 Aaron Zornes 33 erythema nodosum 33 nonadherence 33 Clinical Competence 33 Critically Ill Patients 33 #,# #,# [003] 33 parameterised 33 Biophysical 33 PROMS 33 Echocardiographic 33 Nutritional Therapy 33 HERKIMER Alzheimer 33 Cardiotoxicity 33 LIFE FANS 33 EID AL 33 IROs 33 C1 INH deficiency 33 www.certicom.com 33 MyPlanIQ 33 comorbid disorders 33 Treatment Resistant 33 Vitamin B9 33 XLTEK 33 Diabetic Patients 33 Rotumans 33 tardive dyskinesia TD 33 Summarize 33 SENSITIVITY 33 FINANCIAL PLANNING 33 www.manpower.com 33 elevated fasting glucose 33 Mantoux 33 George Lewith 33 neurosensory 33 WikiWealth.com 33 WAIVER OF 33 boxed WARNING 33 GLUCOSE 33 oral hypoglycemic 33 Left Ventricular Dysfunction 33 IFIS 33 CPMP 33 PRESS RELEASES 33 MEs 33 preoperatively 33 OTDs 33 MEDICAL OFFICE 33 Quantitative RT PCR 33 CYP# [001] 33 cirrhotic 33 Subclinical 33 TRUST AND 33 Blennow 33 www.aboutschwab.com 33 Spirometry 33 International Nonproprietary Name 33 FINANCIAL RESULTS PHONE NO 33 norepinephrine transporter 33 REVIEW REPORT 33 Clinically 33 hepatologists 33 CRB disclosure 33 GOVERN 33 PMBOK Guide 33 Student Loan Borrower 33 zur des 33 syndromic 33 preop 33 psychometrically 33 TRENDS AND 33 QUALITY OF 33 LDL HDL 33 anemia leukopenia 33 #,#,# #,#,# SHAREHOLDERS EQUITY [002] 33 QUESTIONS OR 33 bolus dosing 33 FSPs 33 INCLUSIVE 33 registered dieticians 33 Gestational Diabetes 33 clinically meaningful differences 33 Cardiometabolic 33 CHAIRMAN 'S 33 FIBROMYALGIA 33 THOMSON REUTERS 33 eClinicalWorks EMR 33 prodromal symptoms 33 Karayiorgou 33 HAVE THE SAME 33 FINANCIAL RESOURCES 33 BANZEL 33 KEVIN HARVICK NO 33 DO NOT NEED 33 MANMOHAN 33 Continuous Disclosure 33 nephronophthisis 33 PREFERRED QUALIFICATIONS 33 Emerging Therapies 33 stavudine d4T 33 haemolytic 33 ACCA qualification 33 Rhinitis 33 Dialectical Behavior Therapy 33 albumin excretion rate 33 TERMS AND 33 Suitable applicants 33 ITIL v2 33 RLAI 33 Continuous Disclosure Policy 33 Medication Compliance 33 iaith 33 angina pectoris 33 HOLBROOKE 33 UA NSTEMI 33 transaminase elevations 33 EFT Manual 33 Borderline Personality Disorder 33 Nucleic Acid Amplification 33 www.seic.com 33 Phe restricted diet 33 Dr. Merera Gudina 33 Mental Component 33 miRview squamous 33 Spasticity 33 suicide attempters 33 m mamta sharma im 33 SINHALA 33 Behaviorally 33 Clinical Decision Making 33 adjunctive therapies 33 Adverse Event 33 gabapentin Neurontin 33 ACARA 33 Zeb Horowitz 33 OP Pohjola Group 33 www.dsm.com 33 CAFCASS 33 Dr Bernd Hentsch 33 Relapsing remitting MS 33 intestinal permeability 33 AND LIQUIDITY 33 bicuspid aortic valves 33 ANALYTICAL 33 LVN RN . 33 VLDL C 33 anthropometric measurements 33 colesevelam 33 Depressive symptoms 33 antiretroviral naïve 33 glaucomatous 33 nonfasting triglyceride levels 33 TELECONFERENCE 33 Exacerbations 33 Penny Herscher 33 Chronic Heart Failure